Nisa Investment Advisors
CAPR icon

Nisa Investment Advisors’s Capricor Therapeutics CAPR Stock Holding History

Nisa Investment Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Buy
583
+166
+40% +$5.03K ﹤0.01% 2377
2026
Q1 		$12.7K Sell
417
-7
-2% -$187 ﹤0.01% 2156
2025
Q4 		$12.2K Sell
424
-29
-6% -$379 ﹤0.01% 2142
2025
Q3 		$3.27K Hold
453
– – ﹤0.01% 2525
2025
Q2 		$4.5K Sell
453
-761
-63% -$8.04K ﹤0.01% 2470
2025
Q1 		$11.5K Buy
1,214
+14
+1% +$194 ﹤0.01% 2064
2024
Q4 		$16.6K Buy
+1,200
New +$21K ﹤0.01% 1995

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nisa Investment Advisors's CAPR Position: Q2 2026 in Review

Nisa Investment Advisors increased its Capricor Therapeutics (CAPR) stake by 40% in Q2 2026, buying an estimated $5.03K and bringing the position to 583 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #2377.

Nisa Investment Advisors first reported a position in CAPR in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.6K in Q4 2024. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Nisa Investment Advisors held 583 shares of Capricor Therapeutics worth $14K as of Q2 2026.
  • Nisa Investment Advisors bought 166 Capricor Therapeutics shares in Q2 2026, an estimated $5.03K.
  • Capricor Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2377 holding.
  • Nisa Investment Advisors first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Nisa Investment Advisors's Capricor Therapeutics position peaked at $16.6K in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.